Parker Institute for Cancer Immunotherapy added Dana-Farber Cancer Institute and Gladstone Institutes to its immuno-oncology research partnership network.
Both institutions will establish new cancer immunology research centers funded by grants from Parker Institute for Cancer Immunotherapy (PICI) as part of their membership.
The goal of the network and its funding is to encourage “bold, high-risk scientific research” with the aim of bringing together academic research and biotech companies for the development of new cancer therapies, according to a PICI-issued press release.
“We